531 related articles for article (PubMed ID: 18720308)
21. Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome.
Pierangeli SS; Vega-Ostertag M; Liu X; Girardi G
Ann N Y Acad Sci; 2005 Jun; 1051():413-20. PubMed ID: 16126983
[TBL] [Abstract][Full Text] [Related]
22. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.
Girardi G; Redecha P; Salmon JE
Nat Med; 2004 Nov; 10(11):1222-6. PubMed ID: 15489858
[TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms.
Pierangeli SS; Chen PP; González EB
Curr Opin Hematol; 2006 Sep; 13(5):366-75. PubMed ID: 16888443
[TBL] [Abstract][Full Text] [Related]
24. Management of antiphospholipid syndrome.
Tuthill JI; Khamashta MA
J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
[TBL] [Abstract][Full Text] [Related]
25. Autoantibody explosion in antiphospholipid syndrome.
Shoenfeld Y; Twig G; Katz U; Sherer Y
J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
[TBL] [Abstract][Full Text] [Related]
26. Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin.
Di Simone N; Meroni PL; D'Asta M; Di Nicuolo F; D'Alessio MC; Caruso A
Hum Reprod Update; 2007; 13(2):189-96. PubMed ID: 17099207
[TBL] [Abstract][Full Text] [Related]
27. The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: a personal history long in the making.
Asherson RA
Semin Thromb Hemost; 2008 Apr; 34(3):227-35. PubMed ID: 18720302
[TBL] [Abstract][Full Text] [Related]
28. Antiphospholipid syndrome.
Erkan D; Lockshin MD
Curr Opin Rheumatol; 2006 May; 18(3):242-8. PubMed ID: 16582686
[TBL] [Abstract][Full Text] [Related]
29. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
Adams M
Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
[TBL] [Abstract][Full Text] [Related]
30. Venous thrombosis in the antiphospholipid syndrome.
Farmer-Boatwright MK; Roubey RA
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
[TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases.
Tănăsescu R; Nicolau A; Caraiola S; Ticmeanu M; Cojocaru IM; Frăsineanu A; Ionescu R; Hristea A; Ene A; Anghel D; Tănăsescu R; Băicuş C
Rom J Intern Med; 2007; 45(4):355-63. PubMed ID: 18767411
[TBL] [Abstract][Full Text] [Related]
32. Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies.
Khamashta MA
J Autoimmun; 2000 Sep; 15(2):249-53. PubMed ID: 10968919
[TBL] [Abstract][Full Text] [Related]
33. Current debates in antiphospholipid syndrome: the acquired antibody-mediated thrombophilia.
Oztürk MA; Haznedaroğlu IC; Turgut M; Göker H
Clin Appl Thromb Hemost; 2004 Apr; 10(2):89-126. PubMed ID: 15094931
[TBL] [Abstract][Full Text] [Related]
34. Update on antiphospholipid syndrome.
Lockshin MD
Bull NYU Hosp Jt Dis; 2006; 64(1-2):57-9. PubMed ID: 17121491
[TBL] [Abstract][Full Text] [Related]
35. [Antiphospholipid antibody syndrome].
Chakoutio V; Ries F
Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174
[TBL] [Abstract][Full Text] [Related]
36. Newer antiphospholipid antibodies predict adverse outcomes in patients with acute coronary syndrome.
Greco TP; Conti-Kelly AM; Greco T; Doyle R; Matsuura E; Anthony JR; Lopez LR
Am J Clin Pathol; 2009 Oct; 132(4):613-20. PubMed ID: 19762540
[TBL] [Abstract][Full Text] [Related]
37. Managing antiphospholipid antibodies and antiphospholipid syndrome in children.
Kamat AV; D'Cruz DP; Hunt BJ
Haematologica; 2006 Dec; 91(12):1674-80. PubMed ID: 17145604
[TBL] [Abstract][Full Text] [Related]
38. IgA antiphospholipid antibodies are an independent risk factor for thromboses.
Shen YM; Lee R; Frenkel E; Sarode R
Lupus; 2008 Nov; 17(11):996-1003. PubMed ID: 18852223
[TBL] [Abstract][Full Text] [Related]
39. Cerebral manifestations in the antiphospholipid (Hughes) syndrome.
Sanna G; D'Cruz D; Cuadrado MJ
Rheum Dis Clin North Am; 2006 Aug; 32(3):465-90. PubMed ID: 16880079
[TBL] [Abstract][Full Text] [Related]
40. High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'.
Pengo V; Ruiz-Irastorza G; Denas G; Andreoli L; Khamashta M; Tincani A
Autoimmun Rev; 2012 Jun; 11(8):577-80. PubMed ID: 22036827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
